SCHEMBL1730047

SCHEMBL1730047

[CH2]C([CH2])([CH2])CO[N+](=O)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1898515 0.83 ALDH1A1 (0.62)
SCHEMBL6360345 0.83 ALDH1A1 (0.62)
SCHEMBL2801955 0.79 ALDH1A1 (0.56)
Pentaerythritol Tetranitrate SCHEMBL920358 0.77 ALDH1A1 (1.00)
Pentaerythritol Tetranitrate SCHEMBL37177 0.77 ALDH1A1 (1.00)
SCHEMBL5151075 0.75 ALDH1A1 (0.52)
SCHEMBL2802430 0.75 ALDH1A1 (0.52)
Pentaerythritol Tetranitrate SCHEMBL5940085 0.74 ALDH1A1 (0.94)
SCHEMBL2220993 0.72 ALDH1A1 (0.62)
SCHEMBL7759159 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1023059-B1 PHARMACEUTICAL PREPARATIONS ALPHARMA ISIS GMBH & CO KG (DE) 2005-12-21 EP claimed
EP-1355649-A2 PHARMACEUTICAL FORMULATION CONTAINING PYRAZOLO 4,3-D]PYRIMIDINE AND NITRATES OR THIENOPYRIMIDINES AND NITRATES MERCK PATENT GmbH (DE) 2003-10-29 EP claimed
WO-2002060449-A2 PHARMACEUTICAL FORMULATION CONTAINING PYRAZOLO[4,3-D]PYRIMIDINE AND NITRATES OR THIENOPYRIMIDINES AND NITRATES MERCK PATENT GMBH (DE) 2002-08-08 WO claimed
EP-1173214-A2 MEDICINAL SUBSTANCE UTILIZATION FOR PREVENTING NITRATE TOLERANCE Alpharma-Isis GmbH &amp; Co. KG (DE) 2002-01-23 EP claimed
WO-2001028534-A2 REDUCTION MODERATORS ALPHARMA-ISIS GMBH & CO. KG (DE) 2001-04-26 WO claimed
EP-1087926-A2 ANALYTIC SUBSTRATES AND ANTIOXIDATIVE AGENTS Alpharma-Isis GmbH &amp; Co. KG (DE) 2001-04-04 EP claimed
WO-2000067731-A2 MEDICINAL SUBSTANCE UTILIZATION FOR PREVENTING NITRATE TOLERANCE ALPHARMA-ISIS GMBH & CO.KG (DE) 2000-11-16 WO claimed
EP-1023059-A2 PHARMACEUTICAL PREPARATIONS ISIS PHARMA GmbH (DE) 2000-08-02 EP claimed
WO-1999067430-A2 ANALYTIC SUBSTRATES AND ANTIOXIDATIVE AGENTS ALPHARMA-ISIS GMBH & CO. KG (DE) 1999-12-29 WO claimed
WO-1999018930-A2 PHARMACEUTICAL PREPARATIONS ISIS PHARMA GMBH (DE) 1999-04-22 WO claimed
US-4118414-A PROPELLANTS EXXON RESEARCH & ENGINEERING CO. (US) 1978-10-03 US claimed
US-20230201132-A1 MONO- AND BIS-NITROSYLATED PROPANEDIOLS FOR THERAPEUTIC USE ATTGENO AB (SE) 2023-06-29 US disclosed
EP-4157234-A1 MONO- AND BIS-NITROSYLATED PROPANEDIOLS FOR THERAPEUTIC USE Attgeno AB (SE) 2023-04-05 EP disclosed
US-20220002223-A1 PROCESSES FOR PREPARING NITROSYLATED PROPANEDIOLS, COMPOSITIONS COMPRISING THE SAME, AND MEDICAL USES THEREOF ATTGENO AB (SE) 2022-01-06 US disclosed
WO-2021239892-A1 MONO- AND BIS-NITROSYLATED PROPANEDIOLS FOR THERAPEUTIC USE ATTGENO AB (SE) 2021-12-02 WO disclosed
WO-1998015521-A1 NEW PENTAERYTHRITOL DERIVATIVES, THEIR PRODUCTION AND USE AND INTERMEDIATES FOR THEIR SYNTHESIS ISIS PHARMA GMBH (DE) 1998-04-16 WO disclosed
EP-0752858-A1 PHARMACEUTICAL PREPARATIONS AND MEDICAMENTS FOR THE PREVENTION AND TREATMENT OF ENDOTHELIAL DYSFUNCTION ISIS PHARMA GMBH (DE) 1997-01-15 EP disclosed
WO-1995026725-A1 PHARMACEUTICAL PREPARATIONS AND MEDICAMENTS FOR THE PREVENTION AND TREATMENT OF ENDOTHELIAL DYSFUNCTION ISIS PHARMA GMBH (DE) 1995-10-12 WO disclosed
US-4118414-A PROPELLANTS EXXON RESEARCH & ENGINEERING CO. (US) 1978-10-03 US disclosed
US-4118414-A PROPELLANTS EXXON RESEARCH & ENGINEERING CO. (US) 1978-10-03 US disclosed